Selected research
Industry Research
In-vitro Toxicity Testing Industry Research Report 2026
Market perspective
The global In-vitro Toxicity Testing market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the In-vitro Toxicity Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the In-vitro Toxicity Testing market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the In-vitro Toxicity Testing market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of In-vitro Toxicity Testing include Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., General Electric Co., Evotec AG, Eurofins GSC Lux Sarl, Charles River Laboratories International Inc., CELTHER POLSKA Sp z o.o. and Bio-Rad Laboratories Inc. and among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global In-vitro Toxicity Testing market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to In-vitro Toxicity Testing.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
In-vitro Toxicity Testing Market by Company
Thermo Fisher Scientific Inc.
Merck KGaA
Agilent Technologies Inc.
General Electric Co.
Evotec AG
Eurofins GSC Lux Sarl
Charles River Laboratories International Inc.
CELTHER POLSKA Sp z o.o.
Bio-Rad Laboratories Inc.
Abbott Laboratories
In-vitro Toxicity Testing Segment by Type
Static Well Plate System
Multi-compartmental Perfused Systems
In-vitro Toxicity Testing Segment by Application
Pharmaceutical and Biotechnology Companies
Academic and Research Institutions
Others
In-vitro Toxicity Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global In-vitro Toxicity Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of In-vitro Toxicity Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of In-vitro Toxicity Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of In-vitro Toxicity Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Static Well Plate System
- Multi-compartmental Perfused Systems
Applications
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutions
- Others
Companies covered
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Agilent Technologies Inc.
- General Electric Co.
- Evotec AG
- Eurofins GSC Lux Sarl
- Charles River Laboratories International Inc.
- CELTHER POLSKA Sp z o.o.
- Bio-Rad Laboratories Inc.
- Abbott Laboratories
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 In-vitro Toxicity Testing by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Static Well Plate System
- 2.2.3 Multi-compartmental Perfused Systems
- 2.3 In-vitro Toxicity Testing by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceutical and Biotechnology Companies
- 2.3.3 Academic and Research Institutions
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 In-vitro Toxicity Testing Breakdown Data by Type
- 3.1 Global In-vitro Toxicity Testing Historic Market Size by Type (2021-2026)
- 3.2 Global In-vitro Toxicity Testing Forecasted Market Size by Type (2027-2032)
4 In-vitro Toxicity Testing Breakdown Data by Application
- 4.1 Global In-vitro Toxicity Testing Historic Market Size by Application (2021-2026)
- 4.2 Global In-vitro Toxicity Testing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global In-vitro Toxicity Testing Market Perspective (2021-2032)
- 5.2 Global In-vitro Toxicity Testing Growth Trends by Region
- 5.2.1 Global In-vitro Toxicity Testing Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 In-vitro Toxicity Testing Historic Market Size by Region (2021-2026)
- 5.2.3 In-vitro Toxicity Testing Forecasted Market Size by Region (2027-2032)
- 5.3 In-vitro Toxicity Testing Market Dynamics
- 5.3.1 In-vitro Toxicity Testing Industry Trends
- 5.3.2 In-vitro Toxicity Testing Market Drivers
- 5.3.3 In-vitro Toxicity Testing Market Challenges
- 5.3.4 In-vitro Toxicity Testing Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top In-vitro Toxicity Testing Players by Revenue
- 6.1.1 Global Top In-vitro Toxicity Testing Players by Revenue (2021-2026)
- 6.1.2 Global In-vitro Toxicity Testing Revenue Market Share by Players (2021-2026)
- 6.2 Global In-vitro Toxicity Testing Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of In-vitro Toxicity Testing Head Office and Area Served
- 6.4 Global In-vitro Toxicity Testing Players, Product Type & Application
- 6.5 Global In-vitro Toxicity Testing Manufacturers Established Date
- 6.6 Global In-vitro Toxicity Testing Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America In-vitro Toxicity Testing Market Size (2021-2032)
- 7.2 North America In-vitro Toxicity Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America In-vitro Toxicity Testing Market Size by Country (2021-2026)
- 7.4 North America In-vitro Toxicity Testing Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe In-vitro Toxicity Testing Market Size (2021-2032)
- 8.2 Europe In-vitro Toxicity Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe In-vitro Toxicity Testing Market Size by Country (2021-2026)
- 8.4 Europe In-vitro Toxicity Testing Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific In-vitro Toxicity Testing Market Size (2021-2032)
- 9.2 Asia-Pacific In-vitro Toxicity Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific In-vitro Toxicity Testing Market Size by Country (2021-2026)
- 9.4 Asia-Pacific In-vitro Toxicity Testing Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America In-vitro Toxicity Testing Market Size (2021-2032)
- 10.2 South America In-vitro Toxicity Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America In-vitro Toxicity Testing Market Size by Country (2021-2026)
- 10.4 South America In-vitro Toxicity Testing Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa In-vitro Toxicity Testing Market Size (2021-2032)
- 11.2 Middle East & Africa In-vitro Toxicity Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa In-vitro Toxicity Testing Market Size by Country (2021-2026)
- 11.4 Middle East & Africa In-vitro Toxicity Testing Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Thermo Fisher Scientific Inc.
- 12.1.1 Thermo Fisher Scientific Inc. Company Information
- 12.1.2 Thermo Fisher Scientific Inc. Business Overview
- 12.1.3 Thermo Fisher Scientific Inc. Revenue in In-vitro Toxicity Testing Business (2021-2026)
- 12.1.4 Thermo Fisher Scientific Inc. In-vitro Toxicity Testing Product Portfolio
- 12.1.5 Thermo Fisher Scientific Inc. Recent Developments
- 12.2 Merck KGaA
- 12.2.1 Merck KGaA Company Information
- 12.2.2 Merck KGaA Business Overview
- 12.2.3 Merck KGaA Revenue in In-vitro Toxicity Testing Business (2021-2026)
- 12.2.4 Merck KGaA In-vitro Toxicity Testing Product Portfolio
- 12.2.5 Merck KGaA Recent Developments
- 12.3 Agilent Technologies Inc.
- 12.3.1 Agilent Technologies Inc. Company Information
- 12.3.2 Agilent Technologies Inc. Business Overview
- 12.3.3 Agilent Technologies Inc. Revenue in In-vitro Toxicity Testing Business (2021-2026)
- 12.3.4 Agilent Technologies Inc. In-vitro Toxicity Testing Product Portfolio
- 12.3.5 Agilent Technologies Inc. Recent Developments
- 12.4 General Electric Co.
- 12.4.1 General Electric Co. Company Information
- 12.4.2 General Electric Co. Business Overview
- 12.4.3 General Electric Co. Revenue in In-vitro Toxicity Testing Business (2021-2026)
- 12.4.4 General Electric Co. In-vitro Toxicity Testing Product Portfolio
- 12.4.5 General Electric Co. Recent Developments
- 12.5 Evotec AG
- 12.5.1 Evotec AG Company Information
- 12.5.2 Evotec AG Business Overview
- 12.5.3 Evotec AG Revenue in In-vitro Toxicity Testing Business (2021-2026)
- 12.5.4 Evotec AG In-vitro Toxicity Testing Product Portfolio
- 12.5.5 Evotec AG Recent Developments
- 12.6 Eurofins GSC Lux Sarl
- 12.6.1 Eurofins GSC Lux Sarl Company Information
- 12.6.2 Eurofins GSC Lux Sarl Business Overview
- 12.6.3 Eurofins GSC Lux Sarl Revenue in In-vitro Toxicity Testing Business (2021-2026)
- 12.6.4 Eurofins GSC Lux Sarl In-vitro Toxicity Testing Product Portfolio
- 12.6.5 Eurofins GSC Lux Sarl Recent Developments
- 12.7 Charles River Laboratories International Inc.
- 12.7.1 Charles River Laboratories International Inc. Company Information
- 12.7.2 Charles River Laboratories International Inc. Business Overview
- 12.7.3 Charles River Laboratories International Inc. Revenue in In-vitro Toxicity Testing Business (2021-2026)
- 12.7.4 Charles River Laboratories International Inc. In-vitro Toxicity Testing Product Portfolio
- 12.7.5 Charles River Laboratories International Inc. Recent Developments
- 12.8 CELTHER POLSKA Sp z o.o.
- 12.8.1 CELTHER POLSKA Sp z o.o. Company Information
- 12.8.2 CELTHER POLSKA Sp z o.o. Business Overview
- 12.8.3 CELTHER POLSKA Sp z o.o. Revenue in In-vitro Toxicity Testing Business (2021-2026)
- 12.8.4 CELTHER POLSKA Sp z o.o. In-vitro Toxicity Testing Product Portfolio
- 12.8.5 CELTHER POLSKA Sp z o.o. Recent Developments
- 12.9 Bio-Rad Laboratories Inc.
- 12.9.1 Bio-Rad Laboratories Inc. Company Information
- 12.9.2 Bio-Rad Laboratories Inc. Business Overview
- 12.9.3 Bio-Rad Laboratories Inc. Revenue in In-vitro Toxicity Testing Business (2021-2026)
- 12.9.4 Bio-Rad Laboratories Inc. In-vitro Toxicity Testing Product Portfolio
- 12.9.5 Bio-Rad Laboratories Inc. Recent Developments
- 12.10 Abbott Laboratories
- 12.10.1 Abbott Laboratories Company Information
- 12.10.2 Abbott Laboratories Business Overview
- 12.10.3 Abbott Laboratories Revenue in In-vitro Toxicity Testing Business (2021-2026)
- 12.10.4 Abbott Laboratories In-vitro Toxicity Testing Product Portfolio
- 12.10.5 Abbott Laboratories Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst